Literature DB >> 19919948

Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease.

Taketoshi Asanuma1, Masafumi Ono, Kei Kubota, Akira Hirose, Yoshihiro Hayashi, Toshiji Saibara, Osamu Inanami, Yasuhiro Ogawa, Hideaki Enzan, Saburo Onishi, Mikinori Kuwabara, Jude A Oben.   

Abstract

BACKGROUND: The pathogenesis of non-alcoholic fatty liver disease (NAFLD) is incompletely understood. Kupffer cells (KCs), phagocytic liver-resident macrophages, provide a protective barrier against egress of endotoxin from the portal to the systemic circulation. It is not known if KC phagocytic function is impaired in NAFLD. Super-paramagnetic iron oxide (SPIO) magnetic resonance imaging is a comparative technology dependent on KC phagocytic function.
OBJECTIVE: To evaluate KC uptake function, in patients and experimental animals with NAFLD, using SPIO.
METHODS: Abdominal CT and histological examination of liver biopsy specimens were used to estimate the degree of steatosis in patients with NAFLD and controls with chronic hepatitis C. SPIO-MRI was then performed in all patients. Normal rats fed a methionine-choline-deficient diet to induce non-alcoholic steatohepatitis (NASH), the more severe stage of NAFLD, and obese, insulin resistant, Zucker fa/fa rats with steatohepatitis, were also studied with SPIO-MRI and analysed for hepatic uptake of fluorescent microbeads. Immunohistochemical analysis evaluated the numbers of KCs in patients and rat livers.
RESULTS: Relative signal enhancement (RSE), inversely proportional to KC function, was higher in patients with NAFLD than in controls and with the degree of steatosis on CT. RSE also positively correlated with the degree of steatosis on histology and was similarly higher in rats with induced severe NAFLD (NASH). On immunohistochemistry, defective phagocytic function was the result of reduced phagocytic uptake and not due to reduced KC numbers in rats or patients with NAFLD.
CONCLUSIONS: KC uptake function is significantly impaired in patients with NAFLD and experimental animals with NASH, worsens with the degree of steatosis and is not due to a reduction of KC numbers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19919948     DOI: 10.1136/gut.2009.176651

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

Review 1.  Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications.

Authors:  Wei Wu; Zhaohui Wu; Taekyung Yu; Changzhong Jiang; Woo-Sik Kim
Journal:  Sci Technol Adv Mater       Date:  2015-04-28       Impact factor: 8.090

2.  NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.

Authors:  Wing-Kin Syn; Kolade M Agboola; Marzena Swiderska; Gregory A Michelotti; Evaggelia Liaskou; Herbert Pang; Guanhua Xie; George Philips; Isaac S Chan; Gamze F Karaca; Thiago de Almeida Pereira; Yuping Chen; Zhiyong Mi; Paul C Kuo; Steve S Choi; Cynthia D Guy; Manal F Abdelmalek; Anna Mae Diehl
Journal:  Gut       Date:  2012-03-17       Impact factor: 23.059

3.  Biomolecular Ultrasound Imaging of Phagolysosomal Function.

Authors:  Bill Ling; Justin Lee; David Maresca; Audrey Lee-Gosselin; Dina Malounda; Margaret B Swift; Mikhail G Shapiro
Journal:  ACS Nano       Date:  2020-09-14       Impact factor: 15.881

4.  Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy using technetium-99m-labelled galactosyl human serum albumin.

Authors:  Tatsuyuki Tonan; Kiminori Fujimoto; Aliya Qayyum; Sanae Azuma; Masatoshi Ishibashi; Takato Ueno; Noriyuki Ono; Junji Akiyoshi; Sunao Matsushita; Naofumi Hayabuchi; Takumi Kawaguchi; Michio Sata
Journal:  Exp Ther Med       Date:  2011-04-11       Impact factor: 2.447

5.  Correlation of liver parenchymal gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid enhancement and liver function in humans with hepatocellular carcinoma.

Authors:  Kei Kubota; Taiji Tamura; Nobutaka Aoyama; Munenobu Nogami; Norihiko Hamada; Akihito Nishioka; Yasuhiro Ogawa
Journal:  Oncol Lett       Date:  2012-03-01       Impact factor: 2.967

Review 6.  Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?

Authors:  Bin Gao; Hidekazu Tsukamoto
Journal:  Gastroenterology       Date:  2016-01-27       Impact factor: 22.682

Review 7.  Interaction between macrophages and ferroptosis.

Authors:  Yan Yang; Yu Wang; Lin Guo; Wen Gao; Ting-Li Tang; Miao Yan
Journal:  Cell Death Dis       Date:  2022-04-16       Impact factor: 9.685

Review 8.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Detlef Schuppan; Henning Grønbæk; Konstantin Kazankov; Simon Mark Dahl Jørgensen; Karen Louise Thomsen; Holger Jon Møller; Hendrik Vilstrup; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

9.  Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease.

Authors:  Stefan Traussnigg; Emina Halilbasic; Harald Hofer; Petra Munda; Tatjana Stojakovic; Günter Fauler; Karl Kashofer; Martin Krssak; Michael Wolzt; Michael Trauner
Journal:  Wien Klin Wochenschr       Date:  2020-09-15       Impact factor: 1.704

10.  Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans.

Authors:  Michiko Itoh; Hideaki Kato; Takayoshi Suganami; Kuniha Konuma; Yoshio Marumoto; Shuji Terai; Hiroshi Sakugawa; Sayaka Kanai; Miho Hamaguchi; Takahiro Fukaishi; Seiichiro Aoe; Kazunari Akiyoshi; Yoshihiro Komohara; Motohiro Takeya; Isao Sakaida; Yoshihiro Ogawa
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.